Balyasny Asset Management’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.48M | Buy |
47,345
+42,281
| +835% | +$3.1M | 0.01% | 1007 |
|
|
2025
Q1 | $578K | Sell |
5,064
-4,416
| -47% | -$504K | ﹤0.01% | 1532 |
|
|
2024
Q4 | $478K | Sell |
9,480
-3,515
| -27% | -$177K | ﹤0.01% | 1490 |
|
|
2024
Q3 | $601K | Buy |
+12,995
| New | +$601K | ﹤0.01% | 1492 |
|
|
2024
Q1 | – | Sell |
-6,993
| Closed | -$227K | – | 2049 |
|
|
2023
Q4 | $227K | Buy |
+6,993
| New | +$227K | ﹤0.01% | 1710 |
|
|
2022
Q1 | – | Sell |
-111,397
| Closed | -$2.21M | – | 2170 |
|
|
2021
Q4 | $2.21M | Buy |
111,397
+67,619
| +154% | +$1.34M | 0.01% | 985 |
|
|
2021
Q3 | $862K | Buy |
+43,778
| New | +$862K | ﹤0.01% | 1151 |
|
|
2020
Q1 | – | Sell |
-53,736
| Closed | -$650K | – | 1081 |
|
|
2019
Q4 | $650K | Buy |
53,736
+30,091
| +127% | +$364K | ﹤0.01% | 855 |
|
|
2019
Q3 | $334K | Sell |
23,645
-49,380
| -68% | -$698K | ﹤0.01% | 882 |
|
|
2019
Q2 | $814K | Buy |
+73,025
| New | +$814K | 0.01% | 995 |
|
|
2018
Q2 | – | Sell |
-33,263
| Closed | -$547K | – | 1632 |
|
|
2018
Q1 | $547K | Buy |
+33,263
| New | +$547K | ﹤0.01% | 1222 |
|
|
2017
Q1 | – | Sell |
-11,704
| Closed | -$85K | – | 1410 |
|
|
2016
Q4 | $85K | Sell |
11,704
-1,198
| -9% | -$8.7K | ﹤0.01% | 1126 |
|
|
2016
Q3 | $84K | Buy |
+12,902
| New | +$84K | ﹤0.01% | 865 |
|
|
2016
Q2 | – | Sell |
-39,140
| Closed | -$183K | – | 1018 |
|
|
2016
Q1 | $183K | Buy |
+39,140
| New | +$183K | ﹤0.01% | 939 |
|